HISTOGENICS CORP — Form D/A

HISTOGENICS CORP of WALTHAM, MA, a company, filed a Form D amendment with the SEC on 2012-11-26. The offering totals $58.3M, of which $37.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Garheng KongDirectorSeattle, WA
Patrick O'DonnellDirectorPittsburgh, PA
Kevin McArdleExecutive OfficerBoston, MA
Patrick O'DonnellExecutive OfficerPittsburgh, PA
Kevin RakinDirectorNew Haven, CT
Peter GreenleafDirectorDurham, NC
Peter GreenleafExecutive OfficerDurham, NC
John JohnsonDirectorChanhassen, MN
Michael LewisDirectorBoulder, CO
Jonathan J LieberDirectorHouston, TX
Adam GridleyDirectorLexington, MA
Adam GridleyExecutive OfficerLexington, MA
Ramesh KumarDirectorCambridge, MA
Manish B PottiDirectorMalvern, PA
Sanjay B SubramanianExecutive OfficerMalvern, PA
Suha B TaspolatogluDirectorMalvern, PA
Shankar MusunuriDirectorMalvern, PA
Shankar MusunuriExecutive OfficerMalvern, PA
Daniel B JorgensenExecutive OfficerMalvern, PA
Prabhavathi B FernandesDirectorMalvern, PA
Kristen B CastilloDirectorMalvern, PA
Kelly B BeckExecutive OfficerMalvern, PA
Uday B KompellaDirectorMalvern, PA
Rasappa B ArumughamExecutive OfficerMalvern, PA
Vijay B TammaraExecutive OfficerMalvern, PA

Other filings by this issuer (6)

FiledFormOfferingSold
2020-05-07D$395$395
2020-05-07D$14.3M$14.3M
2016-10-12D$30.0M$30.0M
2014-01-06D$20.6M$10.3M
2012-07-27D$58.0M$37.5M
2011-05-26D$34.3M

More